NMR Reaction-Monitoring as a Process Analytical Technique - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

NMR Reaction-Monitoring as a Process Analytical Technique
The authors describe the benefits of nuclear magnetic resonance (NMR) compared with traditional monitoring techniques. They also discuss how NMR reaction monitoring provides a new process analytical technology tool for industry.

Pharmaceutical Technology
pp. s19-s21


1. M.A. Bernstein, Spectrosc. Eur. 19, 11–13 (2007).

2. S.K. Kuster, E. Danieli, B. Blumich, and F. Casanova, Phys. Chem. Chem. Phys. 13, 13172–13176 (2011).

3. M. Maiwald, H. H. Fischer, Y.K. Kim, K. Albert, and H. Hasse, Jrnl. Magn. Reson. 166 (2) 135–146 (2004).

4. M.A. Bernstein, M. Stefinovic, and C.J. Sleigh, Magn. Reson. Chem. 45 (7) 564–571 (2007).

5. J. Sudmeier, U.L. Gunther, K. Albert, and W. Bachovchin, Jrnl. Mag. Res. A, 118 (2) 145–156 (1996).

6. D.B. Green, J. Lane, and R.M. Wing, Appl. Spectrosc. 41 (5) 847–851 (1987).

7. M. Khajeh, M. A. Bernstein, and G. A. Morris, Magn. Reson. Chem. 48 (7) 516–522 (2010).

8. Mestrelab Research, http://mestrelab.com/.

9. M. Zell et al., presentation at SMASH—Small Molecule NMR Conference (Portland, 2010).

10. D.A. Foley et al., J. Org. Chem. (2011) in press.

11. A.C. Barrios Sosa et al., Org. Process Res. Dev. 15 (4) 444–454 (2011).


blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests
Source: Pharmaceutical Technology,
Click here